Pay in 4 interest-free payments of $6.54 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Signs you are escalating too fast Watch for these indicators that your dose is advancing too quickly for your postpartum body: Persistent nausea lasting more than three days after a dose increase Inability to consume at least 1,500 calories daily (1,800 or more if breastfeeding) Noticeable drop in breast milk supply Fatigue significantly worse than your postpartum baseline Weight loss exceeding three pounds per week consistently Dizziness or lightheadedness, especially when standing If any of these occur, the standard recommendation is to hold at your current dose for an additional four weeks before attempting another increase
*Text editing: Maria Kirmanidou
doi:10.1016/j.rbmo.2014.02.004
IGF-1 LR3: not FDA-approved and chemically distinct from the FDA-approved pediatric drug Increlex
Semaglutide was originally developed for diabetes under the brand name Ozempic but was approved by the FDA for weight loss in 2021 under the name Wegovy
